Javascript is not enabled.

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again.

Skip to content
Content starts here
CLOSE ×
Search
CLOSE ×
Search
Leaving AARP.org Website

You are now leaving AARP.org and going to a website that is not operated by AARP. A different privacy policy and terms of service will apply.

aade03db-8fad-4231-87f9-5ddd49df358a

Quiz: What Do You Know About Weight Loss Medications?

Test your knowledge of the popular drugs


woman squatting on the beach illustration
Pete Ryan

This quiz was created with the assistance of generative AI. It was reviewed by editors before publication.

Question 1 of 9

The medications Ozempic, Wegovy, Zepbound, and Mounjaro are best known for treating what conditions?

They are classified as GLP-1 receptor agonists, which help regulate blood sugar and can also promote weight loss.

Question 2 of 9

Which medication was recently approved to treat sleep apnea in adults with obesity?

Zepbound, initially approved for weight loss, received FDA approval in December 2024 to treat moderate to severe obstructive sleep apnea in obese adults. This makes it the first medication approved specifically for this condition.

Question 3 of 9

What is the mechanism by which GLP-1 medications help reduce cravings?

GLP-1 medications are known to help reduce cravings by calming the brain's signals related to hunger and desire, making individuals feel less inclined to give in to food cravings or other addictive behaviors.

Question 4 of 9

According to research, what health conditions might be improved with GLP-1 medications besides weight loss?

Recent studies suggest that GLP-1 medications can help with a variety of conditions, including reducing the risk of kidney problems, heart disease, and even dementia.

Unlock Access to AARP Members Edition

Join AARP to Continue

Already a Member?

Question 5 of 9

How much did semaglutide (Ozempic and Wegovy) reduce the risk of heart attacks and strokes in a clinical trial?

The large clinical trial led to FDA approval of Wegovy for this indication.

Question 6 of 9

What did a 2024 study find about the effect of tirzepatide (Mounjaro and Zepbounon) on blood pressure?

The effect was potentially attributed to both weight loss and the medication itself.

Question 7 of 9

Which medication was approved to reduce the risk of kidney problems in people with type 2 diabetes and chronic kidney disease?

Ozempic, originally a diabetes medication, was approved after a clinical trial demonstrated its benefits in reducing kidney problems.

Question 8 of 9

Which of the following is NOT a known benefit of GLP-1 medications according to recent research?

GLP-1 medications do not increase muscle mass and, in fact, there is concern about muscle loss in older adults, especially when combined with weight loss.

Question 9 of 9

How much can GLP-1 medications cost per month without insurance coverage?

The cost makes insurance coverage necessary for many who could benefit from the medications.

You have unanswered questions. Please go back and complete those questions to finish the quiz.

0 Correct
0 Incorrect
Oops...something went wrong. Please log out and log back in to continue.